Core Insights - The company reported a significant increase in revenue and net profit for the first three quarters of 2025, with revenue reaching 3.786 billion and net profit growing by 220.39% to 469 million [1] - The third quarter alone saw revenue of 1.34 billion, a year-on-year increase of 11.42%, and net profit soaring by 485.77% to 198 million [1] - Key drivers of this performance include improved industry supply-demand dynamics, increased product pricing, and enhanced operational efficiency [1] Financial Performance - For the first three quarters of 2025, the company achieved total revenue of 3.786 billion, a 12.04% increase year-on-year, and net profit of 469 million, marking a 220.39% increase [1] - The third quarter's net profit per share was 1.09, up 179.49% from 0.39 in the same period last year [1] Asset and Equity Growth - As of September 30, 2025, total assets reached 7.904 billion, a 10.75% increase from the previous year, while equity attributable to shareholders surged by 98.33% to 5.650 billion, primarily due to a targeted issuance of shares [2] Debt and Cash Flow Management - The company has optimized its debt structure, with short-term borrowings significantly reduced and total current liabilities decreasing from 2.751 billion to 1.653 billion [3] - Net cash flow from operating activities for the first three quarters was 502 million, an 86.56% increase, driven by revenue growth and improved profitability [3] Expense Control - Sales expenses increased slightly by 1.79%, while management and R&D expenses rose by 11.88% and 8.14%, respectively; financial expenses decreased by 25.59%, enhancing profitability [3] - Continuous investment in R&D supports technological innovation and product development, maintaining a competitive edge in the industry [3] Shareholder Structure - New institutional investors have emerged among the top ten shareholders, including the Central Enterprise Rural Industry Investment Fund and Ganzhou Development Investment Fund Management Co., Ltd. [3]

Core Insights - Yonghe Co., Ltd. reported significant growth in both revenue and net profit for Q3 and the first three quarters of the year [1][3] Financial Performance - In Q3, the company achieved revenue of 1.34 billion yuan, an increase of 11.42% year-on-year [1][3] - The net profit attributable to shareholders in Q3 was 198 million yuan, a substantial increase of 485.77% year-on-year [1][3] - For the first three quarters, Yonghe's revenue reached 3.786 billion yuan, reflecting a year-on-year growth of 12.04% [1][3] - The net profit attributable to shareholders for the first three quarters was 469 million yuan, representing a year-on-year increase of 220.39% [1][3] Factors Contributing to Growth - The increase in product prices and gross margin was influenced by the quota for third-generation refrigerants [1][3] - The expansion of production and sales scale of major polymer products, along with an improvement in product quality, contributed to the growth [1][3] - Enhanced management and cost control measures have also played a role in improving profitability [1][3]

Group 1 - Yonghe Co., Ltd. reported a net profit of 469 million yuan for the first three quarters, a year-on-year increase of 220.39% [1] - Jinli Permanent Magnet achieved a net profit of 515 million yuan, reflecting a year-on-year growth of 161.81% [1][2] - Sanhe Pharmaceutical Auxiliary's net profit increased by 8.28% year-on-year, reaching 133 million yuan [2] Group 2 - Jiahuan Technology experienced a net profit decline of 26.53%, totaling 55.35 million yuan [3] - Wuchan Huaneng reported a net profit decrease of 15.10%, amounting to 453 million yuan [3] - Chuan Investment Energy's net profit fell by 4.54%, totaling 4.22 billion yuan [4][5] Group 3 - Dayang Bio's net profit grew by 56.12%, reaching 80 million yuan [5] - Weili Medical reported a net profit increase of 14.94%, totaling 192 million yuan [6] - People's Tongtai's net profit decreased by 45.69%, amounting to 112 million yuan [7] Group 4 - Jiuhuan Bio received a medical device registration certificate for its NT-proBNP test kit [8] - Jincheng Pharmaceutical's subsidiary obtained a drug registration certificate for a specific injection [9] - Guangdian Yuntong's subsidiary acquired a money service operator license in Hong Kong [10] Group 5 - Dash Intelligent won a bid for a project worth 96 million yuan related to the Shijiazhuang subway [10] - Alloy Investment's net profit increased by 124.87%, reaching 7.26 million yuan [11] - Kaile Co., Ltd. reported a net profit growth of 159.14%, totaling 21.63 million yuan [12] Group 6 - Chuanjinno's net profit surged by 175.61%, reaching 304 million yuan [14] - Rijiu Optoelectronics reported a net profit increase of 36.54%, totaling 76.91 million yuan [15] - Dazhu CNC's net profit grew by 142.19%, amounting to 492 million yuan [15] Group 7 - Nairui Radar expects a net profit increase of 181% for the first three quarters [17] - Suzhou Tianmai successfully acquired land use rights for a new manufacturing project [19] - Aokai Pharmaceutical announced clinical research data for its innovative drug at a major conference [21][22] Group 8 - Jilin Aodong's subsidiary passed the consistency evaluation for a specific injection [24] - Qinxin Environment announced the resignation of a board member [25] - *ST Baoying is planning a change in control, leading to a stock suspension [26] Group 9 - Jianlang Hardware's director plans to reduce holdings by up to 500,000 shares [27] - Taihe Technology's director intends to reduce holdings by up to 606,000 shares [29] - Zhongyuan Securities announced a cash dividend of 0.008 yuan per share [31] Group 10 - Beijing-Shanghai High-Speed Railway plans to distribute a cash dividend of 0.0385 yuan per share [32] - Zhuhai Guanyu expects a net profit increase of 36.88%-55.54% for the first three quarters [34] - Shenglong Co., Ltd. reported a net loss of 72.95 million yuan for the first three quarters [36] Group 11 - Shuangyuan Technology plans to distribute a cash dividend of 0.125 yuan per share [38] - Shaanxi Guotou A reported a net profit increase of 6.6%, totaling 996 million yuan [40] - Sunshine Nuohua intends to invest 15 million yuan in a biotech company [41] Group 12 - Yangjie Technology's net profit increased by 45.51%, reaching 974 million yuan [42] - Xingwang Yuda reported a net profit growth of 260%, totaling 38.37 million yuan [43] - Tongyou Technology turned a profit with a net profit of 9.29 million yuan [44]

证券代码：605020 证券简称：永和股份 公告编号：2025-090 浙江永和制冷股份有限公司 2025 年前三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 浙江永和制冷股份有限公司（以下简称"公司"）根据上海证券交易所《上海证 券交易所上市公司自律监管指引第 3 号——行业信息披露》及其附件《第十三号—— 化工》有关规定，将公司 2025 年前三季度主要经营数据披露如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 产量（吨） | 同比 | 对外销量 | 同比 | 营业收入 | 同比 | | --- | --- | --- | --- | --- | --- | --- | | | | （%） | （吨） | （%） | （万元） | （%） | | 氟碳化学品 | 123,452.31 | 1.51 | 68,030.08 | -9.00 | 203,887.72 | 18.00 | | 含氟高分子材料 | 42,070.80 | 14.90 | 29,026.58 | -1.5 ...

为保证公司内部审计工作的正常开展，根据《中华人民共和国公司法》《上海 证券交易所上市公司自律监管指引第 1 号——规范运作》等规定，经公司董事会审 计委员会提名，公司董事会同意聘任余利霞女士为审计中心负责人，负责公司内部 审计工作，任期自本次董事会审议通过之日起至第四届董事会任期届满之日止。 证券代码：605020 证券简称：永和股份 公告编号：2025-089 浙江永和制冷股份有限公司 关于聘任审计中心负责人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江永和制冷股份有限公司（以下简称"公司"）于 2025 年 10 月 20 日召开 第四届董事会第二十四次会议，审议通过《关于聘任审计中心负责人的议案》，现 将相关情况公告如下： 一、审计中心负责人离任情况 刘水芳女士因公司内部工作岗位调动，不再担任公司审计中心负责人，仍在公 司担任其他职务。公司董事会对刘水芳女士在担任公司审计中心负责人期间为公司 发展作出的贡献表示衷心的感谢！ 二、聘任审计中心负责人的情况 附件：余利霞女士简历 特此公告。 浙江永和制冷股份有限 ...

证券代码：605020 证券简称：永和股份 公告编号：2025-088 浙江永和制冷股份有限公司 关于 2024 年员工持股计划预留份额分配的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江永和制冷股份有限公司（以下简称"公司"）于 2025 年 10 月 20 日召开 2024 年员工持股计划管理委员会第一次会议及第四届董事会第二十四次会议，审 议通过《关于 2024 年员工持股计划预留份额分配的议案》。根据《浙江永和制冷 股份有限公司 2024 年员工持股计划（草案修订稿）》（以下简称"《持股计划》 （草案修订稿）"）《浙江永和制冷股份有限公司 2024 年员工持股计划管理办法 （修订稿）》（以下简称"《管理办法》（修订稿）"）的有关规定，以及公司 2024 年第二次临时股东大会的授权，本次预留份额分配事项在董事会授权审批范 围内，无需提交公司股东会审议： 司 2024 年员工持股计划管理委员会委员的议案》及《关于授权公司 2024 年员工持 股计划管理委员会办理本期员工持股计划相关事宜的议案》。 （四）2024 ...

格隆汇10月20日丨永和股份(605020.SH)公布，公司前三季度实现营业收入37.86亿元，同比增长 12.04%；归属于上市公司股东的净利润4.69亿元，同比增长220.39%；归属于上市公司股东的扣除非经 常性损益的净利润4.57亿元，同比增长223.74%；基本每股收益1.09元。 ...

浙江永和制冷股份有限公司2025 年第三季度报告 证券代码：605020 证券简称：永和股份 浙江永和制冷股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告 期末比上年 | | --- | --- | --- | --- | --- | | | | 期增减变 | 年初至报告期末 | 同期增减变 | | | | 动幅度 | | 动幅度(%) | | | | (%) | | | | 营业收入 | 1,340,096,465.12 | 11.42 | 3,785, ...

Core Insights - Yonghe Co., Ltd. reported a significant increase in both revenue and net profit for Q3 2025, with revenue reaching 1.34 billion yuan, a year-on-year growth of 11.42%, and net profit at 198 million yuan, a remarkable increase of 485.77% [1] Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 3.786 billion yuan, reflecting a year-on-year growth of 12.04%, while net profit stood at 469 million yuan, marking a substantial increase of 220.39% [1] - The primary drivers for these performance improvements include the impact of third-generation refrigerant quotas leading to continuous price increases, an expansion in the production and sales scale of major polymer products, and enhanced quality rates [1] Operational Efficiency - The company has strengthened lean management and cost control measures, which have contributed to an improved profit margin [1]

证券代码：605020 证券简称：永和股份 公告编号：2025-087 浙江永和制冷股份有限公司 关于调整 2024 年员工持股计划 预留份额购买价格的公告 一、本员工持股计划已履行的审议程序 （一）2024 年 9 月 27 日，公司召开职工代表大会、第四届董事会第十二次会 议及第四届监事会第九次会议，审议通过《关于公司<2024 年员工持股计划（草案）> 及其摘要的议案》《关于公司<2024 年员工持股计划管理办法>的议案》及《关于 提请股东大会授权董事会办理公司 2024 年员工持股计划相关事宜的议案》，同意 公司实施本员工持股计划。 （二）2024 年 10 月 9 日，公司召开第四届董事会第十三次会议、第四届监事 会第十次会议，并于 2024 年 10 月 28 日召开 2024 年第二次临时股东大会，审议通 过《关于公司<2024 年员工持股计划（草案修订稿）>及其摘要的议案》《关于公 司<2024 年员工持股计划管理办法（修订稿）>的议案》及《关于提请股东大会授 权董事会办理公司 2024 年员工持股计划相关事宜的议案》，股东会同意授权董事 会办理与本员工持股计划相关的事宜。 1/3 （三）20 ...